J&J Wins China’s First Price Monopoly Lawsuit
This article was originally published in PharmAsia News
Johnson & Johnson has won China’s first price monopoly lawsuit brought by their 15-year partner Beijing Firmness Science & Technology Co. Ltd. May 18.
You may also be interested in...
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
Early Research Suggests Wearables Can Spot Early Signs Of COVID-19; Fitbit Receives $2.5m Army Award
A consortium of researchers, including Fitbit, are developing algorithms to spot COVID-19 before people become ill.